Humacyte, Inc. (HUMA) Misses Q2 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- S&P 500, Nasdaq advance as oil eases ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts HUMA Hot Sheet
Join SI Premium – FREE
Humacyte, Inc. (NASDAQ: HUMA) reported Q2 EPS of ($0.24), $0.08 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $301 thousand versus the consensus estimate of $1.01 million.
For earnings history and earnings-related data on Humacyte, Inc. (HUMA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX shares continue higher following Anthropic's $120.5bn AI deal
- StoneX Reiterates Buy Rating on Rambus Inc. (RMBS) Stock, 'Puzzled' by Post-Earnings Weakness
- Cipher Digital rises as AI data center rebuttal lifts sector
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
